Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | -113.07% |
| Q3 2025 | 2340.22% |
| Q2 2025 | 108.32% |
| Q1 2025 | -375.88% |
| Q4 2024 | -43.22% |
| Q3 2024 | 508.87% |
| Q2 2024 | 93.73% |
| Q1 2024 | -35.87% |
| Q4 2023 | 42.11% |
| Q3 2023 | -12.61% |
| Q2 2023 | 15.46% |
| Q1 2023 | -26.20% |
| Q4 2022 | 8.85% |
| Q3 2022 | -44.28% |
| Q2 2022 | 4.07% |
| Q1 2022 | 0.83% |
| Q4 2021 | 33.28% |
| Q3 2021 | -31.03% |
| Q2 2021 | 16.06% |
| Q1 2021 | -207.98% |
| Q4 2020 | 242.23% |
| Q3 2020 | -5.86% |
| Q2 2020 | 12.97% |
| Q1 2020 | -32.02% |
| Q4 2019 | -53.13% |
| Q3 2019 | -34.31% |
| Q2 2019 | -12.22% |
| Q1 2019 | 20.05% |
| Q4 2018 | -34.24% |
| Q3 2018 | -7.94% |
| Q2 2018 | -33.83% |
| Q1 2018 | -47.66% |
| Q4 2017 | -39.46% |
| Q3 2017 | 3.13% |
| Q2 2017 | -36.44% |
| Q1 2017 | -28.76% |
| Q4 2016 | -0.48% |
| Q3 2016 | -0.63% |
| Q2 2016 | 0.00% |
| Q1 2016 | 8.09% |